順誠(00531.HK)擬7004萬美元出售基金投資權益
格隆匯9月16日丨順誠(00531.HK)公告,於2019年12月18日,SIE(公司全資附屬公司)出售部分其根據授權協議向UBP所設立子基金(UBP專用SICAV-SIF-全球投資組合系列1)作出的投資。有關出售投資的本金金額為6950萬美元及出售事項的代價為7004萬美元。公司確認出售事項所得收益為53.65萬美元。
子基金的投資目標為於產生固定收益的同時試圖提供資產的長期資本增值,其投資政策主要為投資於固定收益工具、貨幣市場工具以及已發展及新興市場投資基金的資產淨值。作為其庫務管理的一部分,公司一直密切監察子基金的表現,並考慮現金流量的靈活性以維持健全的資產負債比率,管理層因此決定出售部分投資。出售事項所得款項已用作資本開支及償還銀行貸款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.